GGrantIndex
← Search

BETA-CATENIN-TCF PATHWAY AND CASTRATE-RESISTANT PROGRESSION OF OSTEBOBLASTIC BONE METASTASES

$561,675FY2008Department of the ArmyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators

View source on USAspending →
BETA-CATENIN-TCF PATHWAY AND CASTRATE-RESISTANT PROGRESSION OF OSTEBOBLASTIC BONE METASTASES · GrantIndex